138 related articles for article (PubMed ID: 19764557)
21. Congenital erythropoietin over-expression causes "anti-pulmonary hypertensive" structural and functional changes in mice, both in normoxia and hypoxia.
Weissmann N; Manz D; Buchspies D; Keller S; Mehling T; Voswinckel R; Quanz K; Ghofrani HA; Schermuly RT; Fink L; Seeger W; Gassmann M; Grimminger F
Thromb Haemost; 2005 Sep; 94(3):630-8. PubMed ID: 16268482
[TBL] [Abstract][Full Text] [Related]
22. Altered pulmonary vascular reactivity in mice with excessive erythrocytosis.
Hasegawa J; Wagner KF; Karp D; Li D; Shibata J; Heringlake M; Bahlmann L; Depping R; Fandrey J; Schmucker P; Uhlig S
Am J Respir Crit Care Med; 2004 Apr; 169(7):829-35. PubMed ID: 14701712
[TBL] [Abstract][Full Text] [Related]
23. BAY 41-2272, a direct activator of soluble guanylate cyclase, reduces right ventricular hypertrophy and prevents pulmonary vascular remodeling during chronic hypoxia in neonatal rats.
Deruelle P; Balasubramaniam V; Kunig AM; Seedorf GJ; Markham NE; Abman SH
Biol Neonate; 2006; 90(2):135-44. PubMed ID: 16582538
[TBL] [Abstract][Full Text] [Related]
24. [Effect of captopril on pulmonary vascular remodeling induced by left-to-right shunt in rats].
Li M; Zhou TF; Liu HM; Hua YM; Wang XM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):242-5. PubMed ID: 16608085
[TBL] [Abstract][Full Text] [Related]
25. [Effect of adrenomedullin on the regulation of pulmonary arterial pressure in hypoxic rats].
Cheng D; Tian W; Chen W; Xiao X
Zhonghua Jie He He Hu Xi Za Zhi; 2002 Jun; 25(6):360-3. PubMed ID: 12126562
[TBL] [Abstract][Full Text] [Related]
26. Polycythemia and changes in erythropoietin concentration in rats exposed to intermittent hypoxia.
Ishii M; Iwamoto T; Nagai A; Sasao G; Iwasaki M; Kuwahira I
Adv Exp Med Biol; 2010; 662():121-6. PubMed ID: 20204781
[TBL] [Abstract][Full Text] [Related]
27. Effect of intermittent normoxia on chronic hypoxic pulmonary hypertension, right ventricular hypertrophy, and polycythemia in rats.
Kay JM
Am Rev Respir Dis; 1980 Jun; 121(6):993-1001. PubMed ID: 6448017
[TBL] [Abstract][Full Text] [Related]
28. [Changes of pulmonary artery structural remodeling in pulmonary hypertension induced by high pulmonary flow in rats].
Li XH; Du JB; Tang XY; Jin HF; Tang CS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Aug; 27(4):446-51. PubMed ID: 16178437
[TBL] [Abstract][Full Text] [Related]
29. [Effect of adrenomedullin 1-50 on chronic hypoxic pulmonary hypertension in rats].
Qi JG; Ding YG; Tang CS; Du JB
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Apr; 38(2):151-4. PubMed ID: 16617356
[TBL] [Abstract][Full Text] [Related]
30. The effect of systemic beta-2 adrenergic agonist therapy on the pulmonary hypertensive response to chronic hypoxia in rats.
Winter R; Collins C; Ruddock PE; Rudd RM
Am Rev Respir Dis; 1986 Oct; 134(4):763-7. PubMed ID: 2876666
[TBL] [Abstract][Full Text] [Related]
31. Phosphodiesterase type 5 as a target for the treatment of hypoxia-induced pulmonary hypertension.
Sebkhi A; Strange JW; Phillips SC; Wharton J; Wilkins MR
Circulation; 2003 Jul; 107(25):3230-5. PubMed ID: 12796132
[TBL] [Abstract][Full Text] [Related]
32. Correlation of inhaled nitric-oxide induced reduction of pulmonary artery pressure and vascular changes.
Jiang BH; Maruyama J; Yokochi A; Amano H; Mitani Y; Maruyama K
Eur Respir J; 2002 Jul; 20(1):52-8. PubMed ID: 12166581
[TBL] [Abstract][Full Text] [Related]
33. [Effect of simvastatin on rat pulmonary hypertension induced by high pulmonary blood flow and injected monocrotaline].
Zhao L; Zhou TF; Liu HM; Li M; Dou H; Tang ZH
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 38(3):463-5, 479. PubMed ID: 17593832
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of NOX/VPO1 pathway and inflammatory reaction by trimethoxystilbene in prevention of cardiovascular remodeling in hypoxia-induced pulmonary hypertensive rats.
Liu B; Luo XJ; Yang ZB; Zhang JJ; Li TB; Zhang XJ; Ma QL; Zhang GG; Hu CP; Peng J
J Cardiovasc Pharmacol; 2014 Jun; 63(6):567-76. PubMed ID: 24492474
[TBL] [Abstract][Full Text] [Related]
35. Pulmonary arterial smooth muscle contractility in hypoxia-induced pulmonary hypertension.
Griffith SL; Rhoades RA; Packer CS
J Appl Physiol (1985); 1994 Jul; 77(1):406-14. PubMed ID: 7961262
[TBL] [Abstract][Full Text] [Related]
36. Effects of sodium tanshinone II A sulphonate on hypoxic pulmonary hypertension in rats in vivo and on Kv2.1 expression in pulmonary artery smooth muscle cells in vitro.
Huang YF; Liu ML; Dong MQ; Yang WC; Zhang B; Luan LL; Dong HY; Xu M; Wang YX; Liu LL; Gao YQ; Li ZC
J Ethnopharmacol; 2009 Sep; 125(3):436-43. PubMed ID: 19635545
[TBL] [Abstract][Full Text] [Related]
37. [The effect of ETA receptor antagonist WS009A on the pathogenesis of hypoxic pulmonary hypertension in rats].
Yang X; Chen W
Hua Xi Yi Ke Da Xue Xue Bao; 2001 Sep; 32(3):409-12. PubMed ID: 12536579
[TBL] [Abstract][Full Text] [Related]
38. [The regulative effcets of A2a adenosine receptor on expression of SOCS-3 in rats of hypoxic pulmonary hypertension].
Fan R; Huang XY; Du KY; Fan YF; Wang LX
Zhonghua Jie He He Hu Xi Za Zhi; 2016 Jun; 39(6):469-73. PubMed ID: 27289578
[TBL] [Abstract][Full Text] [Related]
39. Effect of chemokine receptor CXCR4 on hypoxia-induced pulmonary hypertension and vascular remodeling in rats.
Yu L; Hales CA
Respir Res; 2011 Feb; 12(1):21. PubMed ID: 21294880
[TBL] [Abstract][Full Text] [Related]
40. Bone marrow-derived cells contribute to pulmonary vascular remodeling in hypoxia-induced pulmonary hypertension.
Hayashida K; Fujita J; Miyake Y; Kawada H; Ando K; Ogawa S; Fukuda K
Chest; 2005 May; 127(5):1793-8. PubMed ID: 15888860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
